Axsome Therapeutics Inc buy BiotechBee
Start price
08.09.22
/
50%
€60.00
Target price
31.12.24
€80.00
Performance (%)
35.00%
End price
24.06.23
€81.00
Summary
This prediction ended on 24.06.23 with a price of €81.00. With a performance of 35.00% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Axsome Therapeutics Inc where he still thinks Axsome Therapeutics Inc is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Axsome Therapeutics Inc | -5.005% | -5.005% | 18.406% |
iShares Core DAX® | -1.958% | 4.037% | 23.702% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% |
According to BiotechBee what are the pros and cons of Axsome Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Axsome Therapeutics Inc diskutieren
Buy mit Kursziel 80,0
In the thread Trading Axsome Therapeutics Inc
Buy beendet
Current prediction by BiotechBee for Axsome Therapeutics Inc
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€81.00
24.06.23
24.06.23
€100.00
31.12.25
31.12.25
-5.33%
07.10.24
07.10.24
Could be very worthwhile Investment >20% year